Board of Directors Change at Nass Valley Gateway

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), announced that the resignation of Milo Filgas as Director and member of the Company’s audit committee had been confirmed on May 30, 2019.  The Company thanked Mr. Filgas for his contributions and looks forward to continue working with him as a member of its Advisory Committee.

At the same board meeting Nass Valley also confirmed the appointment of Mr. Darren Palestine as his replacement in both board positions. Mr. Palestine received his Masters of Art Degree in “International Business” from the University of Florida in 2009 and is a Board Member of Commercial Finance Association (CFA)-Board Member since 2011 and has been managing the day to day business of “Commercial Finance Partners” as Managing Partner and COO since 2016.

The Company also wishes to announce the resignation of Mr. Eric Peter-Kaiser as Director and member of the Company’s audit committee to be effective as of June 3, 2019 and the resignations of Messrs. Dieter Peter as Chairman and Director as well as Andrew von Kursell as Director and audit committee member effective June 5, 2019.

Nass Valley acknowledges the contributions of all three gentlemen over the past few years, especially their respective positive involvement in administrative matters and keeping the company always in good standing.

The Company’s President and CEO, Mr. John Peter Affenita commented, “We will announce the new appointments to the Board and open Committee positions very shortly and I am convinced that with the industry leading knowledge of its new team members Nass Valley will fulfil its objectives to be well positioned in the “Life Science” sector of the Canadian Securities Exchange and meet the challenges of its planned vertical integration within the CBD sector”.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.